Oligometastatic Cancer: Evidence from a Danish National Cohort Study

Michael Teindl Laursen, MD, PhD Student, Department of Oncology, Herlev and Gentofte Hospital, Denmark, presents a nationwide Danish cohort study on oligometastatic cancer treated with local ablative therapies such as surgery, radiotherapy, and thermal ablation. The project explores prognostic modeling, longitudinal disease trajectories, and innovative endpoints, while creating a platform for embedded sub-studies and future randomized trials across diverse patient populations.